Market Research Logo

Metabolic Disorders Drugs Market Global Briefing 2019

Metabolic Disorders Drugs Market Global Briefing 2019 Including: Anti Diabetics drugs; Anti-Thyroid drugs; Others (Hyperparathyroidism, Hypopituitarism, Hypoadrenalism) Covering: Sanofi S.A.; Eli Lilly And Company; Merck & Co.; Novo Nordisk; Astrazeneca

North America was the largest region in the metabolic disorders drugs market worth $35.2 billion in 2018, accounting for 53.5% of the global metabolic disorders drugs market, followed by Western Europe at 19.7% and Asia Pacific at 16.6% respectively.

Metabolic Disorders Drugs Global Market Briefing 2019 provides strategists, marketers and senior management with the critical information they need to assess the global metabolic disorders drugs sector.

Reasons to Purchase

  • Fully updated for 2019.
  • Identify growth segments and opportunities.
  • Facilitate decision making on the basis of historic and forecast data and understand the drivers and restraints on the market.
  • Develop strategies based on likely future developments.
  • Gain a global perspective on the development of the market.
Description

Metabolic Disorders Drugs Global Market Briefing from the Business Research Company covers market characteristics, size and growth, segmentation, regional breakdowns, competitive landscape, market shares, trends and strategies for this market.

The market characteristics section of the report defines and explains the market.

The market size section gives the metabolic disorders drugs market revenues, covering both the historic growth of the market and forecasting the future.

Drivers and restraints looks at the external factors supporting and controlling the growth of the market.

Market segmentations break down the key sub sectors which make up the market. The regional breakdowns section gives the size of the market geographically.

Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in the last three years are identified.

The trends and strategies section highlights the likely future developments in the metabolic disorders drugs market and suggests approaches.

Scope

Markets Covered: Anti Diabetics drugs; Anti-Thyroid drugs; Others (Hyperparathyroidism, Hypopituitarism, Hypoadrenalism)

Companies Mentioned: Sanofi S.A.; Eli Lilly And Company; Merck & Co.; Novo Nordisk; Astrazeneca

Geographic scope: Asia Pacific, North America, Western Europe, Eastern Europe, South America, Middle East, Africa

Countries: Australia, China, Hong Kong, India, Indonesia, Japan, South Korea, Malaysia, New Zealand, Philippines, Singapore, Thailand, Vietnam, Canada, USA, Mexico, Argentina, Brazil, Chile, Colombia, Peru, Venezuela, Austria, Belgium, Denmark, Finland, France, Germany, Ireland, Italy, Netherlands, Norway, Portugal, Spain, Sweden, Switzerland, the UK, Czech Republic, Poland, Romania, Russia, Israel, Saudi Arabia, Turkey, UAE, Egypt, Nigeria, South Africa

Time series: Five years historic and forecast

Data: Market value in $ billions.

Data segmentations: Regional breakdowns, market share of competitors, key sub segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.


Metabolic Disorders Drugs Market Characteristics
Metabolic Disorders Drugs Market Trends And Strategies
Development Of New Anti-Diabetic Drugs For Type 2 Diabetes
Enzyme Replacement Therapies For The Treatment Of Rare Metabolic Disorders
Increase In Mergers And Acquisitions
Metabolic Disorders Drugs Market Historic Growth
Metabolic Disorders Drugs Market Forecast Growth
Metabolic Disorders Drugs Market Segmentation
Global Metabolic Disorders Drugs Market, Split By Segment, 2018, $ Billion
Anti Diabetics Drugs
Anti-Thyroid Drugs
Others (Hyperparathyroidism, Hypopituitarism, Hypoadrenalism)
Global Metabolic Disorders Drugs Market, Historic And Forecast, Split By Segment, 2014-2022
Metabolic Disorders Drugs Market Geography Regional Comparison
Global Metabolic Disorders Drugs Market, Split By Region, 2018, $ Billion
Global Metabolic Disorders Drugs Market, Historic And Forecast Growth Rate, Split By Region, 2014-2022
Asia Pacific Metabolic Disorders Drugs Market Analysis
Asia Pacific Metabolic Disorders Drugs Market, 2014 – 2022
Asia Pacific Metabolic Disorders Drugs Market, Split By Country, 2018
Asia Pacific Metabolic Disorders Drugs Market, Historic And Forecast Growth Rate, Split By Country, 2014 – 2022
Asia Pacific Metabolic Disorders Drugs Market, Per Capita Average Expenditure, By Country, 2018
North America Metabolic Disorders Drugs Market Analysis
North America Metabolic Disorders Drugs Market, 2014 – 2022
North America Metabolic Disorders Drugs Market, Split By Country, 2018
North America Metabolic Disorders Drugs Market, Historic And Forecast Growth Rate, Split By Country, 2014 – 2022
North America Metabolic Disorders Drugs Market, Per Capita Average Expenditure, By Country, 2018
Western Europe Metabolic Disorders Drugs Market Analysis
Western Europe Metabolic Disorders Drugs Market, 2014 – 2022
Western Europe Metabolic Disorders Drugs Market, Split By Country, 2018
Western Europe Metabolic Disorders Drugs Market, Historic And Forecast Growth Rate, Split By Country, 2014 – 2022
Western Europe Metabolic Disorders Drugs Market, Per Capita Average Expenditure, By Country, 2018
Eastern Europe Metabolic Disorders Drugs Market Analysis
Eastern Europe Metabolic Disorders Drugs Market, 2014 – 2022
Eastern Europe Metabolic Disorders Drugs Market, Split By Country, 2018
Eastern Europe Metabolic Disorders Drugs Market, Historic And Forecast Growth Rate, Split By Country, 2014 – 2022
Eastern Europe Metabolic Disorders Drugs Market, Per Capita Average Expenditure, By Country, 2018
South America Metabolic Disorders Drugs Market Analysis
South America Metabolic Disorders Drugs Market, 2014 – 2022
South America Metabolic Disorders Drugs Market, Split By Country, 2018
South America Metabolic Disorders Drugs Market, Historic And Forecast Growth Rate, Split By Country, 2014 – 2022
South America Metabolic Disorders Drugs Market, Per Capita Average Expenditure, By Country, 2018
Africa Metabolic Disorders Drugs Market Analysis
Africa Metabolic Disorders Drugs Market, 2014 – 2022
Africa Metabolic Disorders Drugs Market, Split By Country, 2018
Africa Metabolic Disorders Drugs Market, Historic And Forecast Growth Rate, Split By Country, 2014 – 2022
Africa Metabolic Disorders Drugs Market, Per Capita Average Expenditure, By Country, 2018
Middle East Metabolic Disorders Drugs Market Analysis
Middle East Metabolic Disorders Drugs Market, 2014 – 2022
Middle East Metabolic Disorders Drugs Market, Split By Country, 2018
Middle East Metabolic Disorders Drugs Market, Historic And Forecast Growth Rate, Split By Country, 2014 – 2022
Middle East Metabolic Disorders Drugs Market, Per Capita Average Expenditure, By Country, 2018
Metabolic Disorders Drugs Market Competitive Landscape
Sanofi S.A,
Eli Lilly And Company
Merck & Co
Novo Nordisk
Astrazeneca
Metabolic Disorders Drugs Market, Key Mergers And Acquisitions
Alexion Acquired Synageva
AstraZeneca Acquired ZS Pharma
Horizon Pharma Plc. Acquired Hyperion Therapeutics, Inc.
Horizon Pharma Plc. Acquired Raptor Pharmaceutical Corp.
Madrigal Pharmaceuticals Merged With Synta Pharmaceuticals Corp.
Appendix
Market Data Sources
NAICS Definitions Of Industry Covered In This Report
Research Methodology
Abbreviations
Currencies
Research Inquiries
The Business Research Company
Copyright And Disclaimer
List of Tables
Table 1: Global Metabolic Disorders Drugs Market, Historic Market Size, 2014-2018, $ Billion 10
Table 2: Global Metabolic Disorders Drugs Market, Forecast Market Size, 2018-2022, $ Billion 11
Table 3: Global Metabolic Disorders Drugs Market, Split By Segment, 2018, $ Billion 13
Table 4: Global Metabolic Disorders Drugs Market, Historic And Forecast, Split By Segment, 2014-2022 14
Table 5: Global Metabolic Disorders Drugs Market, Split By Region, 2018, $ Billion 16
Table 6: Global Metabolic Disorders Drugs Market, Historic And Forecast Growth Rate, Split By Region, 2014-2022 18
Table 7: Asia Pacific Metabolic Disorders Drugs Market, 2014-2022, $ Billion 20
Table 8: Asia Pacific Metabolic Disorders Drugs Market, Split By Country, 2018, $ Billion 22
Table 9: Asia Pacific Metabolic Disorders Drugs Market, Historic And Forecast Growth Rate, Split By Country, 2014-2022 24
Table 10: Asia Pacific Metabolic Disorders Drugs Market, Per Capita Average Expenditure, By Country, 2018 26
Table 11: North America Metabolic Disorders Drugs Market, 2014-2022, $ Billion 28
Table 12: North America Metabolic Disorders Drugs Market, Split By Country, 2018, $ Billion 29
Table 13: North America Metabolic Disorders Drugs Market, Historic And Forecast Growth Rate, Split By Country, 2014-2022 31
Table 14: North America Metabolic Disorders Drugs Market, Per Capita Average Expenditure, By Country, 2018 32
Table 15: Western Europe Metabolic Disorders Drugs Market, 2014-2022, $ Billion 34
Table 16: Western Europe Metabolic Disorders Drugs Market, Split By Country, 2018, $ Billion 36
Table 17: Western Europe Metabolic Disorders Drugs Market, Historic And Forecast Growth Rate, Split By Country, 2014-2022 38
Table 18: Western Europe Metabolic Disorders Drugs Market, Per Capita Average Expenditure, By Country, 2018 40
Table 19: Eastern Europe Metabolic Disorders Drugs Market, 2014-2022, $ Billion 42
Table 20: Eastern Europe Metabolic Disorders Drugs Market, Split By Country, 2018, $ Billion 44
Table 21: Eastern Europe Metabolic Disorders Drugs Market, Historic And Forecast Growth Rate, Split By Country, 2014-2022 46
Table 22: Eastern Europe Metabolic Disorders Drugs Market, Per Capita Average Expenditure, By Country, 2018 47
Table 23: South America Metabolic Disorders Drugs Market, 2014-2022, $ Billion 49
Table 24: South America Metabolic Disorders Drugs Market, Split By Country, 2018, $ Billion 51
Table 25: South America Metabolic Disorders Drugs Market, Historic And Forecast Growth Rate, Split By Country, 2014-2022 53
Table 26: South America Metabolic Disorders Drugs Market, Per Capita Average Expenditure, By Country, 2018 54
Table 27: Africa Metabolic Disorders Drugs Market, 2014-2022, $ Billion 55
Table 28: Africa Metabolic Disorders Drugs Market, Split By Country, 2018, $ Billion 56
Table 29: Africa Metabolic Disorders Drugs Market, Historic And Forecast Growth Rate, Split By Country, 2014-2022 58
Table 30: Africa Metabolic Disorders Drugs Market, Per Capita Average Expenditure, By Country, 2018 59
Table 31: Middle East Metabolic Disorders Drugs Market, 2014-2022, $ Billion 61
Table 32: Middle East Metabolic Disorders Drugs Market, Split By Country, 2018, $ Billion 63
Table 33: Middle East Metabolic Disorders Drugs Market, Historic And Forecast Growth Rate, Split By Country, 2014-2022 65
Table 34: Middle East Metabolic Disorders Drugs Market, Per Capita Average Expenditure, By Country, 2018 66
Table 35: Global Metabolic Disorders Drugs Market, Key Competitors Estimated Market Shares, 2018, Percentage (%) 68
Table 36: Metabolic Disorders Drugs Market Data Sources 73
List of Figures
Figure 1: Global Metabolic Disorders Drugs Market, Historic Market Size, 2014-2018, $ Billion 11
Figure 2: Global Metabolic Disorders Drugs Market, Forecast Market Size, 2018-2022, $ Billion 12
Figure 3: Global Metabolic Disorders Drugs Market, Split By Segment, 2018, $ Billion 13
Figure 4: Global Metabolic Disorders Drugs Market, Historic And Forecast, Split By Segment, 2014-2022 15
Figure 5: Global Metabolic Disorders Drugs Market, Split By Region, 2018, $ Billion 16
Figure 6: Global Metabolic Disorders Drugs Market, Historic And Forecast Growth Rate, Split By Region, 2014-2022 18
Figure 7: Asia Pacific Metabolic Disorders Drugs Market, 2014-2022, $ Billion 20
Figure 8: Asia Pacific Metabolic Disorders Drugs Market, Split By Country, 2018, $ Billion 22
Figure 9: Asia Pacific Metabolic Disorders Drugs Market, Historic And Forecast Growth Rate, Split By Country, 2014 - 2022 24
Figure 10: Asia Pacific Metabolic Disorders Drugs Market, Per Capita Average Expenditure, By Country, 2018 26
Figure 11: North America Metabolic Disorders Drugs Market, 2014-2022, $ Billion 28
Figure 12: North America Metabolic Disorders Drugs Market, Split By Country, 2018, $ Billion 30
Figure 13: North America Metabolic Disorders Drugs Market, Historic And Forecast Growth Rate, Split By Country, 2014 - 2022 31
Figure 14: North America Metabolic Disorders Drugs Market, Per Capita Average Expenditure, By Country, 2018 33
Figure 15: Western Europe Metabolic Disorders Drugs Market, 2014-2022, $ Billion 34
Figure 16: Western Europe Metabolic Disorders Drugs Market, Split By Country, 2018, $ Billion 36
Figure 17: Western Europe Metabolic Disorders Drugs Market, Historic And Forecast Growth Rate, Split By Country, 2014 - 2022 38
Figure 18: Western Europe Metabolic Disorders Drugs Market, Per Capita Average Expenditure, By Country, 2018 40
Figure 19: Eastern Europe Metabolic Disorders Drugs Market, 2014-2022, $ Billion 42
Figure 20: Eastern Europe Metabolic Disorders Drugs Market, Split By Country, 2018, $ Billion 44
Figure 21: Eastern Europe Metabolic Disorders Drugs Market, Historic And Forecast Growth Rate, Split By Country, 2014 - 2022 46
Figure 22: Eastern Europe Metabolic Disorders Drugs Market, Per Capita Average Expenditure, By Country, 2018 48
Figure 23: South America Metabolic Disorders Drugs Market, 2014-2022, $ Billion 49
Figure 24: South America Metabolic Disorders Drugs Market, Split By Country, 2018, $ Billion 51
Figure 25: South America Metabolic Disorders Drugs Market, Historic And Forecast Growth Rate, Split By Country, 2014 - 2022 53
Figure 26: South America Metabolic Disorders Drugs Market, Per Capita Average Expenditure, By Country, 2018 55
Figure 27: Africa Metabolic Disorders Drugs Market, 2014-2022, $ Billion 56
Figure 28: Africa Metabolic Disorders Drugs Market, Split By Country, 2018, $ Billion 57
Figure 29: Africa Metabolic Disorders Drugs Market, Historic And Forecast Growth Rate, Split By Country, 2014 - 2022 58
Figure 30: Africa Metabolic Disorders Drugs Market, Per Capita Average Expenditure, By Country, 2018 60
Figure 31: Middle East Metabolic Disorders Drugs Market, 2014-2022, $ Billion 61
Figure 32: Middle East Metabolic Disorders Drugs Market, Split By Country, 2018, $ Billion 63
Figure 33: Middle East Metabolic Disorders Drugs Market, Historic And Forecast Growth Rate, Split By Country, 2014 - 2022 65
Figure 34: Middle East Metabolic Disorders Drugs Market, Per Capita Average Expenditure, By Country, 2018 67
Figure 35: Global Metabolic Disorders Drugs Market, Key Competitor Estimated Market Shares, 2018, Percentage (%) 68

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report